[1]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039-1042.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
 LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(7):1039-1042.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
点击复制

急性心肌梗死后心脏破裂()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年7期
页码:
1039-1042
栏目:
综述
出版日期:
2019-10-25

文章信息/Info

Title:
Post-infarction Cardiac Rupture
作者:
林莉 韦铁民
(丽水市中心医院心内科,浙江 丽水 323000)
Author(s):
LIN LiWEI Tiemin
(Department of CardiologyLishui Municipal Central Hospital, Lishui, Zhejiang 323000, China.)
关键词:
心脏破裂急性心肌梗死危险因素
Keywords:
Acute myocardial infarctionCardiac rupturerisk factors
DOI:
10.16806/j.cnki.issn.1004-3934.2019.07.019
摘要:

随着现代医学的不断进步,心脏疾患的治疗成功率大大改善。但是,目前国内心血管疾病的死亡率仍然在不断上升,根据世界卫生组织最新发表的全球疾病状况的评估报告显示,缺血性心脏病仍然是全球第一大致死原因。而缺血性心脏病死亡比例中,急性心肌梗死所占的比例最大,而急性心肌梗死后心脏破裂是最为严重的并发症。 经皮冠脉介入 技术不断发展的时代,探讨如何 识别 急性心梗死后 心脏破裂的高危人群以及 如何救治和预防 心脏破裂 对于心血管疾病的的发展有重要意义。最近有越来越多的临床研究关注急性心肌梗死后心脏破裂发生。现就心脏破裂的发病机制、心脏破裂发生的危险因素、心脏破裂的分型、诊断及特点、影响心脏破裂预后的因素、 心脏破裂的 治疗和 预防 等方面的的研究现状开展论述。

Abstract:
With the continuous progress of modern medicine, the success rate of heart disease treatment has greatly improved. However, the mortality rate of cardiovascular diseases in China is still rising. According to the latest World Health Organization assessment of global disease status, ischemic heart disease is still the first leading cause of death in the world. Acute myocardial infarction accounts for the largest proportion of ischemic heart disease deaths, and rupture of the heart after acute myocardial infarction is the most serious complication. In the era of continuous development of percutaneous coronary intervention technology, it is of great significance to explore how to identify the high-risk population of heart rupture after acute myocardial infarction and how to treat and prevent heart rupture for the development of cardiovascular diseases. Recently, more and more clinical studies have focused on the occurrence of cardiac rupture after acute myocardial infarction. In this paper, the pathogenesis of cardiac rupture, risk factors of cardiac rupture, classification, diagnosis and characteristics of cardiac rupture, factors affecting the prognosis of cardiac rupture, treatment and prevention of cardiac rupture are discussed

参考文献/References:

[1].López-Sendón J,Gurfinkel EP,Lopez DSE,et al.Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events[J] .Eur Heart J,2010,31(12):1449-1456.
[2].Sulzgruber P,El-Hamid F,Koller L,et al.Long-term outcome and risk prediction in patients suffering acute myocardial infarction complicated by post-infarction cardiac rupture[J].Int J Cardiol,2017,227(1):399-403.
[3].Qian G,Jin RJ,Fu ZH,et al.Development and validation of clinical risk score to predict the cardiac rupture in patients with STEMI[J].Am J Emerg Med,2017,35(4):589-593.
[4].Solomon SDPfeffer MA.Renin—angiotensin system and cardiac rupture after myocardial infarction[J].Circulation 2002,106(17):2167-2169.
[5].胡嘉禄, 黎音亮, 颜彦,等.51例急性心肌梗死合并心脏破裂的临床特征及预后[J].复旦学报(医学版),2015,42(2):198-203.
[6].Nagai T,Honda S,Sugano Y,et a1.Decreased myocardial dendritic cells is associated with impaired reparative fibrosis and development of cardiac rupture after myocardial infarction in humans[J].J Am Heart Assoc,2014,3(3)e000839.
[7].Birnbaum Y, Chamoun AJ, Anzuini A,et al.Ventricular free wall rupture following acute myocardial infarction[J]. Coron Artery Dis,2003,14(6):463470.
[8].Chang RY,Tsai HL,Hsiao PG,et al.Comparison of the risk of left ventricularfree wall rupture in Taiwanese patients with ST-elevation acute myocardial infarction undergoing different reperfusion strategies.A medical record review studyJ].Medicine,2016,95(44):e5308.
[9].缪黄泰,刘子衿,聂绍平.急性心肌梗死类型与心脏破裂发生情况分析J].中华实用诊断与治疗杂志,2016,30(9):872-874.
[10].Radford MJ, Johnson RA, Daggett WJ, et al. Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival[J]. Circulation, 1981,64(3):545-553.
[11].刘子衿,缪黄泰,聂绍平.急性心肌梗死后心脏破裂的危险因素分析J].中华心血管病杂志,2016,44(10):862-867.
[12].Kehl DWIqbal N,Fard A,et al.Biomarkers in acute myocardial injury[J].Transl Res,2012,159(4):252-264.
[13].Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction[J]. J Am Coll Cardiol,1996,27(6):1321–1326.
[14].Honda S, Asaumi Y, Yamane T, et al. Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years[J]. J Am Heart Assoc,2014,3(5): e000984.
[15].Purcaro A, Costantini C, Ciampani N,et al.Diagnostic criteria and management of subacute ventricular free wall rupture complicating acute myocardial infarction[J]. Am J Cardiol,1997,80(4):397-405.
[16].Crenshaw BS, Granger CB, Birnbaum Y,et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction: GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators[J]. Circulation,2000, 101(1): 27-32.
[17].缪黄泰,聂绍平.心肌梗死后心脏破裂[J].中华急诊医学杂志,2015,24(6): 688-689.
[18].Figueras J, Curós A, Cortadellas J, et al. Reliability of electromechanical dissociation in the diagnosis of left ventricular free wall rupture in acute myocardial infarction[J]. Am Heart J,1996, 131(5):861-864.
[19].Ptaszyńska-Kopczyńska K,Sobolewska D,Kozueh M,et a1.Efficacy of invasive treatment and the occurrence of cardiac rupture in acute ST-elevation myocardial infarction[J].Kardiol Pol,201l,69(8):795-800.
[20].Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J].Eur Heart J,2018,39(2):119-177.
[21].Nozoe M, Sakamoto T, Taguchi E, et al. Clinical manifestation of early phase left ventricular rupture complicating acute myocardial infarction in the primary PCI era[J]. J Cardiol, 2014,63(1):14-18.
[22].Gong W,Feng ST,Wang X,et al.Beta-blockers reduced the risk of cardiac rupture in patients with acute myocardial infarction:a meta-analysis of randomized control trials[J].Int J Cardiol,2017,232(4):171-175.
[23].缪黄泰, 张明, 刘子衿, 等. 急性心肌梗死患者并发不同部位心脏破裂的临床特征和预后分析[J]. 中华危重病急救医学,2016,28(12):1080-1085.
[24].Leitman M, Tsatskin L, Hendler A, et al. Cardiac Rupture: New Features of the Old Disease[J]. Cardiology, 2016,133(4):257-261.
[25].Zhang ZP, Su X, Liu CW,et al.Use of intra-aortic balloon pump support for oozing-type cardiac rupture after acute myocardial infarction[J]. Am J Emerg Med,2016,34(1):120.e1-3.
[26].叶家欣,葛敏,王东进.急性心肌梗死后心脏破裂的治疗体会[J].中华心血管病杂志,2018,46(7):554-558.
[27].Cinq-Mars A, Voisine P, Dagenais F,et al.Risk factors of mortality after surgical correction of ventricular septal defect following myocardial infarction: Retrospective analysis and review of the literature[J].Int J Cardiol,2016,206(3): 27-36.
[28].Okonogi T, Otsuka Y, Saito T. Repaired left ventricular free wall rupture after acute myocardial infarction by percutaneous intrapericardial fibrin-glue injection therapy[J]. J Invasive Cardiol,2013,25(9):E186-E187.
[29].Jones BM,?Kapadia SR,?Smedira NG,et al.Ventricular septal rupture complicating acute myocardial infarction: a contemporary review[J].?European Heart Journal, 2014, 35(31),2060-2068.
[30].Yang JH, Hahn JY, Song YB, et al. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. JACC Cardiovasc Interv,2014,7(6):592-601.
[31].Leuschner F,Panizzi P,chico-calero I, et a1. Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir jn mice with myocardial infarction[J].Circ Res,2010,107(11):1364-1373.

相似文献/References:

[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
 LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(7):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
 ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(7):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
 YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(7):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
 YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(7):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
 YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
 WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
 YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(7):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[8]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
 CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(7):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[9]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
 PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(7):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
[10]朱建中 吴倩芸 刘峰.急性ST段抬高型心肌梗死“导管室误激活”的临床进展[J].心血管病学进展,2019,(5):739.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.019]
 ZHU JianzhongWU QianyunLIU Feng.The Development of False-positive Activation of Cardiac Catheterization Laboratory with Acute ST Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(7):739.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.019]
[11]王娟琳 黄颖.急性心肌梗死后心脏破裂机制的研究进展[J].心血管病学进展,2022,(7):619.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
 WANG Juanlin,HUANG Ying.Mechanism of Cardiac Rupture After Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(7):619.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]

备注/Memo

备注/Memo:
收稿日期:2019-03-12基金项目: ()
更新日期/Last Update: 2019-12-17